Literature DB >> 6739375

Prostatic adenocarcinoma PC EW, a new human tumor line transplantable in nude mice.

W Hoehn, M Wagner, J F Riemann, P Hermanek, E Williams, R Walther, R Schrueffer.   

Abstract

A serially transplantable human prostatic carcinoma line, PC EW, has been developed through heterotransplantation of tumor tissue from a lymph node metastasis. PC EW is androgen dependent and is similar to the original tumor in terms of histological pattern, amounts of prostatic acid phosphatase secreted, and absence of a hormonally independent subline. This line is thus similar to PC 82, and we herein report the first results of comparative treatment trials conducted on PC EW.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6739375     DOI: 10.1002/pros.2990050409

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  13 in total

Review 1.  The human prostatic carcinoma cell line LNCaP and its derivatives. An overview.

Authors:  G J van Steenbrugge; M Groen; J W van Dongen; J Bolt; H van der Korput; J Trapman; M Hasenson; J Horoszewicz
Journal:  Urol Res       Date:  1989

2.  Nuclear protein as a prognostic factor of growth activity in prostatic adenocarcinoma.

Authors:  G R Dohle; J A Beekhuis; G J van Steenbrugge; F H Schröder; H J Tanke
Journal:  Urol Res       Date:  1996

Review 3.  Human prostate cancer heterotransplants: a review on this experimental model.

Authors:  Lluis A Lopez-Barcons
Journal:  Asian J Androl       Date:  2010-04-05       Impact factor: 3.285

4.  A better defined medium for human prostate cancer cells.

Authors:  T G Pretlow; G S Ogrinc; S B Amini; C M Delmoro; K F Molkentin; J K Willson; T P Pretlow
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-07       Impact factor: 2.416

Review 5.  Patient-derived xenografts as in vivo models for research in urological malignancies.

Authors:  Takahiro Inoue; Naoki Terada; Takashi Kobayashi; Osamu Ogawa
Journal:  Nat Rev Urol       Date:  2017-02-21       Impact factor: 14.432

6.  Development of seven new human prostate tumor xenograft models and their histopathological characterization.

Authors:  W M van Weerden; C M de Ridder; C L Verdaasdonk; J C Romijn; T H van der Kwast; F H Schröder; G J van Steenbrugge
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

7.  Clinical and experimental progression of a new model of human prostate cancer and therapeutic approach.

Authors:  G de Pinieux; M E Legrier; F Poirson-Bichat; Y Courty; R Bras-Gonçalves; A M Dutrillaux; F Némati; S Oudard; R Lidereau; P Broqua; J L Junien; B Dutrillaux; M F Poupon
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

8.  A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49.

Authors:  Lawrence D True; Kent Buhler; Janna Quinn; Emily Williams; Peter S Nelson; Nigel Clegg; Jill A Macoska; Thomas Norwood; Alvin Liu; William Ellis; Paul Lange; Robert Vessella
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

9.  Prostatic acid phosphatase in the serially transplantable human prostatic tumor lines PC-82 and PC-EW.

Authors:  Z Csapo; K Brand; K M Schrott; B Schwindl
Journal:  Urol Res       Date:  1990

10.  Neuroendocrine differentiation in human prostatic tumor models.

Authors:  M A Noordzij; W M van Weerden; C M de Ridder; T H van der Kwast; F H Schröder; G J van Steenbrugge
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.